Table: Taiko Pharmaceutical -2016/17 parent results
May 12 (Reuters)-
Taiko Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2017 Mar 31, 2016 Mar 31, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 7.82 7.64
(+2.4 pct) (-10.4 pct)
Operating 1.36 1.08
(+25.3 pct) (-53.1 pct)
Recurring 1.22 1.69
(-28.2 pct) (-33.9 pct)
Net 878 mln 1.29
(-32.1 pct) (-22.5 pct)
EPS 63.98 yen 100.49 yen
EPS Diluted 63.44 yen 98.32 yen
Ann Div 20.00 yen 15.00 yen 15.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 20.00 yen 15.00 yen 15.00 yen
NOTE - Taiko Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T
((Tokyo Headline News Desk +813 6441 1812))